For each of the patients below, identify the most appropriate clinical preventive action based on current United States Preventive Services Task Force (USPSTF) guidelines.
- A 71-year-old male presenting for an annual wellness exam. He denies any current tobacco use but reports he smoked a total of approximately 150 cigarettes during a stressful period in his early 20s. He has not had any previous vascular screening tests.Perform one-time screening with abdominal ultrasonography.
- A 36-year-old healthy female of Ashkenazi Jewish descent presenting for a routine check-up. She has absolutely no known personal or family history of any malignancies.Administer a brief familial risk assessment tool for genetic susceptibility.
- A 67-year-old female presenting to establish care. She underwent a loop electrosurgical excision procedure for cervical intraepithelial neoplasia (CIN) 3 at age 54. Her records document three consecutive negative HPV and cytology cotests over the past decade.Continue routine screening with primary HPV testing, cytology, or cotesting.
- A 54-year-old male presenting for a physical. He has a 35-pack-year smoking history but successfully quit all tobacco products exactly 16 years ago. He is up to date on his colorectal cancer screening.Withhold low-dose computed tomography (LDCT) of the chest.
Answer
The 71-year-old male matches with one-time abdominal ultrasonography. The 36-year-old female matches with the brief familial risk assessment tool. The 67-year-old female matches with continued routine cervical screening. The 54-year-old male matches with withholding low-dose computed tomography of the chest.
This matching set tests high-yield exceptions and strict thresholds in USPSTF guidelines. The 71-year-old male requires AAA screening because the 'ever smoked' criteria is precisely defined as 100 or more lifetime cigarettes. The 36-year-old female requires a brief familial risk assessment tool because Ashkenazi Jewish ancestry alone is a sufficient trigger, regardless of her lack of family history. The 67-year-old female must continue cervical cancer screening because a history of CIN 2 or 3 mandates 20 years of continued screening after treatment, superseding the typical age-65 stop date. Finally, the 54-year-old male does not qualify for lung cancer screening because the benefit of LDCT is no longer supported once smoking cessation occurred more than 15 years ago.
Step-by-Step Solution
Key Concept
Nuanced exceptions and strict numerical thresholds in USPSTF Grade A and B clinical preventive screening guidelines.